- UroToday Home
- Recent Abstracts
- Pelvic Health & Reconstruction
Overactive Bladder
The impact of Mirabegron on sexual function in women with idiopathic overactive bladder.
January 27, 2019
Overactive urinary bladder in elderly female patients: treatment specificities and drug interactions.
January 20, 2019
Effectiveness and persistence of mirabegron as a first-line treatment in patients with overactive bladder in real-life practice.
January 13, 2019
Prevalence, Risk Factors, and Treatment for Overactive Bladder in a Racially Diverse Population.
January 6, 2019
Risk factors for persistent, de novo and overall overactive bladder syndrome after surgical prolapse repair.
January 6, 2019
Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience.
December 30, 2018
Higher urge severity score predicts resumption of overactive bladder (OAB) medication following discontinuation of mirabegron treatment in patients with OAB.
December 30, 2018
Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review.
December 23, 2018
FDA Approves Smart Programmer for the InterStim™ System
December 17, 2018
A prospective randomized clinical trial comparing two doses of AbobotulinumtoxinA for idiopathic overactive bladder.
December 16, 2018
Cost-effectiveness of overactive bladder treatments: from the US payer perspective.
December 16, 2018
Feasibility of using a novel non-invasive ambulatory tibial nerve stimulation device for the home-based treatment of overactive bladder symptoms.
December 9, 2018
Initial clinical experience with selective bladder denervation for refractory overactive bladder.
December 9, 2018
Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome.
December 2, 2018